Home6541 • TPE
add
Tanvex Biopharma Inc
Previous close
$57.60
Day range
$57.60 - $59.90
Year range
$47.70 - $81.32
Market cap
15.68B TWD
Avg Volume
698.99K
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
In the news
Financials
Income Statement
Revenue
Net income
| (TWD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 125.34M | 989.60% |
Operating expense | 123.98M | -58.80% |
Net income | -273.50M | 14.12% |
Net profit margin | -218.21 | 92.12% |
Earnings per share | — | — |
EBITDA | -243.08M | 9.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.39B | 87.72% |
Total assets | 8.18B | 173.42% |
Total liabilities | 2.17B | 18.02% |
Total equity | 6.00B | — |
Shares outstanding | 264.82M | — |
Price to book | 2.54 | — |
Return on assets | -9.50% | — |
Return on capital | -10.26% | — |
Cash Flow
Net change in cash
| (TWD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -273.50M | 14.12% |
Cash from operations | -221.46M | 4.81% |
Cash from investing | -217.16M | -282.56% |
Cash from financing | 1.21B | 3,437.00% |
Net change in cash | 822.07M | 588.65% |
Free cash flow | -138.49M | -19.53% |
About
Founded
2013
Website
Employees
200
